IL23R single nucleotide polymorphisms could be either beneficial or harmful in ulcerative colitis

被引:6
作者
Fischer, Sarah [1 ]
Koevesdi, Erzsebet [2 ,3 ]
Magyari, Lili [2 ,3 ]
Csoengei, Veronika [2 ,3 ]
Hadzsiev, Kinga [2 ,3 ]
Melegh, Bela [2 ,3 ]
Hegyi, Peter [4 ,5 ]
Sarlos, Patricia [1 ,5 ]
机构
[1] Univ Pecs, Dept Internal Med 1, Div Gastroenterol, 12 Szigeti St, H-7624 Pecs, Hungary
[2] Univ Pecs, Dept Med Genet, H-7624 Pecs, Hungary
[3] Szentagothai Res Ctr, H-7624 Pecs, Hungary
[4] Univ Pecs, Inst Translat Med, H-7624 Pecs, Hungary
[5] Univ Pecs, Dept Med 1, Div Translat Med, H-7624 Pecs, Hungary
关键词
IL23R gene; ulcerative colitis; phenotype; polymorphism; Hungarian; INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; SUSCEPTIBILITY; RECEPTOR; GENE; INTERLEUKIN-17; METAANALYSIS; RS1004819; PSORIASIS;
D O I
10.3748/wjg.v23.i3.447
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM To investigate the association of seven single nucleotide polymorphisms (SNPs) of the IL23R gene with the clinical picture of ulcerative colitis (UC). METHODS Genomic DNA samples of 131 patients (66 males, 65 females, mean age 55.4 +/- 15.8 years) with Caucasian origin, diagnosed with UC were investigated. The diagnosis of UC was based on the established clinical, endoscopic, radiological, and histopathological guidelines. DNA was extracted from peripheral blood leukocytes by routine salting out method. Polymerase chain reaction and restriction fragment length polymorphism were used to identify the alleles of seven SNPs of IL23R gene (rs11209026, rs10889677, rs1004819, rs2201841, rs7517847, rs10489629, rs7530511). RESULTS Four out of seven analyzed SNPs had statistically significant influence on the clinical picture of UC. Two SNPs were associated with greater colonic extension (rs2201841 P = 0.0084; rs10489629 P = 0.0405). For two of the SNPs, there was more frequently need for operations (rs2201841 P = 0.0348, OR = 8.0; rs10889677 P = 0.0347, OR = 8.0). The rs2201841 showed to be a risk factor for the development of iron deficiency (P = 0.0388, OR = 6.1837). For patients with the rs10889677, a therapy with azathioprine was more frequently necessary (P = 0.0116, OR = 6.1707). Patients with rs10489629 SNP had a lower risk for weight loss (P = 0.0169, OR = 0.3394). Carriers of the heterozygous variant had a higher risk for an extended disease (P = 0.0284). The rs7517847 showed a protective character leading to mild bowel movements. Three SNPs demonstrated no statistically significant influence on any examined clinical features of UC. CONCLUSION We demonstrated susceptible or protective character of the investigated IL23R SNPs on the phenotype of UC, confirming the genetic association.
引用
收藏
页码:447 / 454
页数:8
相关论文
共 32 条
[21]  
Online Mendelian inheritance in man, INT 23 ALPH
[22]   Briakinumab for Treatment of Crohn's Disease: Results of a Randomized Trial [J].
Panaccione, Remo ;
Sandborn, William J. ;
Gordon, Glenn L. ;
Lee, Scott D. ;
Safdi, Alan ;
Sedghi, Shahriar ;
Feagan, Brian G. ;
Hanauer, Stephen ;
Reinisch, Walter ;
Valentine, John F. ;
Huang, Bidan ;
Carcereri, Roberto .
INFLAMMATORY BOWEL DISEASES, 2015, 21 (06) :1329-1340
[23]   Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn's disease and psoriasis [J].
Safrany, Eniko ;
Szabo, Melinda ;
Szell, Marta ;
Kemeny, Lajos ;
Sumegi, Katalin ;
Melegh, Bela I. ;
Magyari, Lili ;
Matyas, Petra ;
Figler, Maria ;
Weber, Agnes ;
Tulassay, Zsolt ;
Melegh, Bela .
INFLAMMATION RESEARCH, 2013, 62 (02) :195-200
[24]   Susceptibility to ulcerative colitis in Hungarian patients determined by gene-gene interactions [J].
Sarlos, Patricia ;
Varszegi, Dalma ;
Csongei, Veronika ;
Magyari, Lili ;
Jaromi, Luca ;
Nagy, Lajos ;
Melegh, Bela .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (01) :219-227
[25]   Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study [J].
Silverberg, Mark S. ;
Cho, Judy H. ;
Rioux, John D. ;
McGovern, Dermot P. B. ;
Wu, Jing ;
Annese, Vito ;
Achkar, Jean-Paul ;
Goyette, Philippe ;
Scott, Regan ;
Xu, Wei ;
Barmada, M. Michael ;
Klei, Lambertus ;
Daly, Mark J. ;
Abraham, Clara ;
Bayless, Theodore M. ;
Bossa, Fabrizio ;
Griffiths, Anne M. ;
Ippoliti, Andrew F. ;
Lahaie, Raymond G. ;
Latiano, Anna ;
Pare, Pierre ;
Proctor, Deborah D. ;
Regueiro, Miguel D. ;
Steinhart, A. Hillary ;
Targan, Stephan R. ;
Schumm, L. Philip ;
Kistner, Emily O. ;
Lee, Annette T. ;
Gregersen, Peter K. ;
Rotter, Jerome I. ;
Brant, Steven R. ;
Taylor, Kent D. ;
Roeder, Kathryn ;
Duerr, Richard H. .
NATURE GENETICS, 2009, 41 (02) :216-220
[26]   Associations between interleukin-23 receptor polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis [J].
Song, Gwan Gyu ;
Bae, Sang-Cheol ;
Choi, Sung Jae ;
Ji, Jong Dae ;
Lee, Young Ho .
MOLECULAR BIOLOGY REPORTS, 2012, 39 (12) :10655-10663
[27]   Marked diversity of IL23R gene haplotype variants in rheumatoid arthritis comparing with Crohn's disease and ankylosing spondylitis [J].
Szabo, Melinda ;
Safrany, Eniko ;
Pazar, Borbala ;
Melegh, Bela I. ;
Kisfali, Peter ;
Poor, Gyula ;
Figler, Maria ;
Szekanecz, Zoltan ;
Czirjak, Laszlo ;
Melegh, Bela .
MOLECULAR BIOLOGY REPORTS, 2013, 40 (01) :359-363
[28]   Association of Single Nucleotide Polymorphisms of IL23R and IL17 with Ulcerative Colitis Risk in a Chinese Han Population [J].
Yu, Pengli ;
Shen, Fangcheng ;
Zhang, Xiaofei ;
Cao, Risheng ;
Zhao, Xiaodan ;
Liu, Pengfei ;
Tu, Huiming ;
Yang, Xiaozhong ;
Shi, Ruihua ;
Zhang, Hongjie .
PLOS ONE, 2012, 7 (09)
[29]   Association of interleukin 23 receptor gene polymorphisms (rs10489629, rs7517847) with rheumatoid arthritis in European population: a meta-analysis [J].
Zhai, Yu ;
Xu, Ke ;
Huang, Fen ;
Peng, Hui ;
Feng, Chen-Chen ;
Zhu, Kao-Kao ;
Leng, Rui-Xue ;
Pan, Hai-Feng ;
Ye, Dong-Qing .
MOLECULAR BIOLOGY REPORTS, 2012, 39 (09) :8987-8994
[30]   After interleukin-12p4O, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease? [J].
Zhang, Zili ;
Hinrichs, David J. ;
Lu, Huiying ;
Chen, Hong ;
Zhong, Wenwei ;
Kolls, Jay K. .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (04) :409-416